Literature DB >> 26612320

Laying open (deroofing) and curettage of sinus as treatment of pilonidal disease: a systematic review and meta-analysis.

Pankaj Garg1, Geetha R Menon2, Vikas Gupta3.   

Abstract

BACKGROUND: Laying open (deroofing, not excision) and curettage of the sinus is a minimally invasive procedure to treat pilonidal disease. A consensus on its efficacy and outcomes has not been reached. We reviewed and meta-analysed the efficacy of this procedure.
METHODS: PubMed, Medline, Scopus, Ovid, Cochrane central register of controlled trials (CENTRAL) and Google scholar databases were searched. All studies describing laying open (not excision) of sinus with curettage of the tract to treat pilonidal disease (simple and complicated) were included. The primary outcome parameter was recurrence and the secondary outcome parameters were complication rate, operating time, return to work and healing time.
RESULTS: A total of 1194 studies were screened. Out of these, 13 studies were finally included for the analysis. The analysis (n = 1445) demonstrated a net proportion meta-analysis (random effect) pooled rate of 4.47% (95% CI = 0.029-0.063) for recurrence, 1.44% (95% CI = 0.005-0.028) for complications, 34.59 min (95% CI = 13.58-55.61) for operating time, 21-72 days for healing time and 8.4 days (95% CI = 5.23-11.72) for return to work. The procedure was possible under local anaesthesia in seven out of 13 studies.
CONCLUSIONS: The meta-analysis demonstrates that laying open (deroofing) and curettage has distinct advantages. These are high success rate, possible in all types of pilonidal disease (simple and complex), low complication rate, short operating time and early return to normal routine and work. This procedure can be conveniently under local anaesthesia as an outpatient procedure.
© 2015 Royal Australasian College of Surgeons.

Entities:  

Keywords:  curettage; excision; meta-analysis; pilonidal sinus; recurrence

Mesh:

Year:  2015        PMID: 26612320     DOI: 10.1111/ans.13377

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  8 in total

1.  A comparison of flap reconstruction vs the laying open technique or excision and direct suture for pilonidal sinus disease: A meta-analysis of randomised studies.

Authors:  Charline Berthier; Emilie Bérard; Thomas Meresse; Jean-Louis Grolleau; Christian Herlin; Benoit Chaput
Journal:  Int Wound J       Date:  2019-06-23       Impact factor: 3.315

Review 2.  Management of sacrococcygeal pilonidal sinus disease.

Authors:  Rhiannon L Harries; Abdullah Alqallaf; Jared Torkington; Keith G Harding
Journal:  Int Wound J       Date:  2018-11-15       Impact factor: 3.315

3.  A minimally invasive approach to pilonidal disease with endoscopic pilonidal sinus treatment (EPSiT): a single-center case series with long-term results.

Authors:  N Foti; D Passannanti; A Libia; F C Campanile
Journal:  Tech Coloproctol       Date:  2021-06-10       Impact factor: 3.781

4.  Endoscopic pilonidal sinus treatment: a systematic review and meta-analysis.

Authors:  Sameh Hany Emile; Hossam Elfeki; Mostafa Shalaby; Ahmad Sakr; Valentina Giaccaglia; Pierpaolo Sileri; Steven D Wexner
Journal:  Surg Endosc       Date:  2018-03-30       Impact factor: 4.584

5.  Anal fistula and pilonidal sinus disease coexisting simultaneously: An audit in a cohort of 1284 patients.

Authors:  Pankaj Garg
Journal:  Int Wound J       Date:  2019-08-14       Impact factor: 3.315

Review 6.  German National Guideline on the management of pilonidal disease: update 2020.

Authors:  I Iesalnieks; A Ommer; A Herold; D Doll
Journal:  Langenbecks Arch Surg       Date:  2021-05-05       Impact factor: 3.445

7.  Re: JSLS. 2017 Jul-Sep; 21(3): e2017.00043. DOI: 10.4293/JSLS.2017.00043. Endoscopic Pilonidal Sinus Treatment: Long-Term Results of a Prospective Series.

Authors:  Pankaj Garg
Journal:  JSLS       Date:  2018 Apr-Jun       Impact factor: 2.172

8.  Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of pilonidal disease.

Authors:  R Perinotti; G Gallo; M Milone; L Basso; M Manigrasso; R Pietroletti; A Bondurri; M La Torre; G Milito; M Pozzo; D Segre
Journal:  Tech Coloproctol       Date:  2021-06-27       Impact factor: 3.781

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.